| Dr John Jeonhwan Chi, MD | |
|
1044 N Mason Rd, Dept Otolaryngology, Ste L10, Creve Coeur, MO 63141-6431 | |
| (314) 996-3880 | |
| (314) 996-8610 |
| Full Name | Dr John Jeonhwan Chi |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 17 Years |
| Location | 1044 N Mason Rd, Creve Coeur, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689872368 | NPI | - | NPPES |
| 200006351 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | 2013009580 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barnes Jewish Hospital | Saint louis, MO | Hospital |
| Barnes-jewish West County Hospital | Creve coeur, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington University | 9830008770 | 2506 |
News Archive
As Americans get heavier and heavier, the incidence of obstructive sleep apnea increases, and results from two clinical studies presented at ANESTHESIOLOGY 2010 reinforce the need for physicians to screen for the disorder prior to surgery in order to appropriately manage the patient in the operating room.
Leading scientists from the UK and around the world will meet at the University of Southampton next week (20 and 21 July) to discuss new technologies to create new, living tissues in the lab and to help our bodies regenerate themselves.
UnitedHealth Group today reported first quarter results, highlighted by strong enrollment and revenue growth in each of UnitedHealthcare's benefits businesses and well-diversified revenue growth at Optum. First quarter 2012 net earnings were $1.31 per share, with continued performance on key financial and operational measures.
Compugen Ltd. announced today the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that there is an increased risk of intrauterine fetal death (IUFD), commonly known as stillbirth, in women who have fibroids.
› Verified 3 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356381842 PECOS PAC ID: 9830008770 Enrollment ID: O20041013000030 |
News Archive
As Americans get heavier and heavier, the incidence of obstructive sleep apnea increases, and results from two clinical studies presented at ANESTHESIOLOGY 2010 reinforce the need for physicians to screen for the disorder prior to surgery in order to appropriately manage the patient in the operating room.
Leading scientists from the UK and around the world will meet at the University of Southampton next week (20 and 21 July) to discuss new technologies to create new, living tissues in the lab and to help our bodies regenerate themselves.
UnitedHealth Group today reported first quarter results, highlighted by strong enrollment and revenue growth in each of UnitedHealthcare's benefits businesses and well-diversified revenue growth at Optum. First quarter 2012 net earnings were $1.31 per share, with continued performance on key financial and operational measures.
Compugen Ltd. announced today the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that there is an increased risk of intrauterine fetal death (IUFD), commonly known as stillbirth, in women who have fibroids.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Jeonhwan Chi, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 996-3880 | Dr John Jeonhwan Chi, MD 1044 N Mason Rd, Dept Otolaryngology, Ste L10, Creve Coeur, MO 63141-6431 Ph: (314) 996-3880 |
News Archive
As Americans get heavier and heavier, the incidence of obstructive sleep apnea increases, and results from two clinical studies presented at ANESTHESIOLOGY 2010 reinforce the need for physicians to screen for the disorder prior to surgery in order to appropriately manage the patient in the operating room.
Leading scientists from the UK and around the world will meet at the University of Southampton next week (20 and 21 July) to discuss new technologies to create new, living tissues in the lab and to help our bodies regenerate themselves.
UnitedHealth Group today reported first quarter results, highlighted by strong enrollment and revenue growth in each of UnitedHealthcare's benefits businesses and well-diversified revenue growth at Optum. First quarter 2012 net earnings were $1.31 per share, with continued performance on key financial and operational measures.
Compugen Ltd. announced today the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that there is an increased risk of intrauterine fetal death (IUFD), commonly known as stillbirth, in women who have fibroids.
› Verified 3 days ago
Dr. Jay F Piccirillo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1044 N Mason Rd, Dept Otolaryngology, Ste L20, Creve Coeur, MO 63141 Phone: 314-362-7509 Fax: 314-362-7522 | |
Dr. Eric Robert Barbarite, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1044 N Mason Rd, Dept Otolaryngology, Ste L10, Creve Coeur, MO 63141 Phone: 314-996-3880 Fax: 314-996-8610 | |
Dr. Nedim Durakovic, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1044 N Mason Rd, Dept Otolaryngology, Ste L20, Creve Coeur, MO 63141 Phone: 314-362-7509 Fax: 314-362-7522 | |
Dr. Gregory H Branham, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1044 N Mason Rd, Dept Otolaryngology, Ste L10, Creve Coeur, MO 63141 Phone: 314-996-3880 Fax: 314-996-8610 | |
Dr. Margaret Naunheim Huston, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1044 N Mason Rd, Dept Otolaryngology, Ste L20, Creve Coeur, MO 63141 Phone: 314-362-7509 Fax: 314-362-7522 | |
Dr. Sai Deepika Challapalli, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1044 N Mason Rd, Dept Otolaryngology, Ste L10, Creve Coeur, MO 63141 Phone: 314-996-3880 Fax: 314-996-8610 | |
Dr. Tamara Kay Ehlert, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 522 N New Ballas Rd, Suite 300, Creve Coeur, MO 63141 Phone: 314-991-9030 Fax: 314-991-9033 |